News

2023

01 May

May 1, 2023

FoodScience®, LLC, and Dechra Veterinary Products Inc. are pleased to announce that Dechra will be the exclusive veterinary distributor of VetriScience Legacy Products in Canada.

keyboard_arrow_right

Read more

2022

20 Jul

July 20, 2022

Dechra announces it has agreed to acquire Piedmont Animal Health, Inc.

Dechra (LSE: DPH) today announces it has agreed to acquire Piedmont Animal Health, Inc ("Piedmont"). Piedmont specializes in developing novel and differentiated products for the companion animal market and has a strong development track record. Piedmont specializes in developing novel and differentiated companion animal products ("CAP") with significant growth potential. Originally founded in 2001 in Greensboro, North Carolina, it has a long and successful track record of product development including major brands launched by multi-national animal health companies. Piedmont employs a development team of 19 people, increasing Dechra's scientific and regulatory capabilities.

keyboard_arrow_right

Read more

2022

20 Jul

July 20, 2022

Dechra announces it has agreed to acquire Piedmont Animal Health, Inc.

Dechra (LSE: DPH) today announces it has agreed to acquire Piedmont Animal Health, Inc ("Piedmont"). Piedmont specializes in developing novel and differentiated products for the companion animal market and has a strong development track record. Piedmont specializes in developing novel and differentiated companion animal products ("CAP") with significant growth potential. Originally founded in 2001 in Greensboro, North Carolina, it has a long and successful track record of product development including major brands launched by multi-national animal health companies. Piedmont employs a development team of 19 people, increasing Dechra's scientific and regulatory capabilities.

keyboard_arrow_right

Read more

2022

01 Jun

June 1, 2022

Dechra Announces VOHC Acceptance for Water Additive

Dechra Veterinary Products is pleased to announce that its VETRADENT® Liquid Water Additive has received the seal of acceptance to Help Control Tartar from the Veterinary Oral Health Council (VOHC). The seal has been granted for dogs after properly demonstrating both safety and efficacy.

keyboard_arrow_right

Read more

2022

01 Jun

June 1, 2022

Taking steps today for a greener tomorrow

Dechra is working on making a difference through sustainable improvements in global animal health and welfare. As such, we created a guide with tips to help Veterinarians and their teams diminish their global impact on the environment. If you are a Veterinarian and would like more information, please contact your Dechra representative

keyboard_arrow_right

Read more

2022

01 Jun

June 1, 2022

Taking steps today for a greener tomorrow

Dechra is working on making a difference through sustainable improvements in global animal health and welfare. As such, we created a guide with tips to help Veterinarians and their teams diminish their global impact on the environment. If you are a Veterinarian and would like more information, please contact your Dechra representative

keyboard_arrow_right

Read more

2021

21 Jun

June 21, 2021

Dechra proudly introduces Mirataz: Veterinary licensed transdermal medication for feline weight control

Unintended weight loss is the #3 reason for pet owners to bring their cat to the veterinarian. Controlling rapid weight loss is critical, and to date has depended on off-label use of oral human medications, which can be difficult to administer and dose accurately.

keyboard_arrow_right

Read more

2021

10 Mar

March 10, 2021

Dechra Veterinary Products Partners with I-MED Pharma

Dechra Veterinary Products is pleased to announce its exclusive marketing, sales, and distribution agreement with I-MED Pharma, the Canadian leader in dry eye management, for three innovative veterinary hyaluronic acid (HA) ophthalmic products.

keyboard_arrow_right

Read more

2021

01 Feb

February 1, 2021

Brand new Dechra Academy launches

Dechra is pleased to announce that the brand new Dechra Academy is now live.

keyboard_arrow_right

Read more

2021

01 Jan

January 1, 2021

NEW! Atipam

ATIPAM is an injectable 5 mg/mL Atipamezole Hydrochloride solution indicated for the reversal of the clinical effects of dexmedetomidine hydrochloride and medetomidine hydrochloride in dogs.

keyboard_arrow_right

Read more

keyboard_arrow_up